The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Between March and September 2026, the Indian pharmaceutical and healthcare industries saw notable structural developments. Given the sector's strong growth prospects, foreign institutional capital flowed into the private hospital industry, which ...
View more details
China has the world's second-largest healthcare market. Its healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand ...
View more details
The Philippine healthcare system consists of both public and private components. Public healthcare is devolved to local government units; meanwhile, the central government operates a limited number of tertiary care and specialist health facilities. ...
View more details
The CEE healthcare and pharma sector sits at the intersection of two converging pressures: a population that is ageing and shrinking faster than its health systems are adapting, and a disease burden shaped by behavioural risk factors that have proven ...
View more details
Poland's healthcare and pharmaceutical sector is one of Central and Eastern Europe's largest and most dynamic markets, characterised by rapid transformation, substantial government investment, and structural financial challenges. Public healthcare ...
View more details
China has the world's second-largest healthcare market. Its healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand ...
View more details
China has the world's second-largest healthcare market. Its healthcare system is hospital-centric, and most inpatient and outpatient care in the country is delivered by public hospitals and basic medical institutions. However, due to growing demand ...
View more details
Southeast Asia is a subregion of the Asian continent which comprises eleven countries, notably Brunei Darussalam, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, Timor Leste, and Vietnam ...
View more details
Indonesia has one of the fastest-growing pharmaceutical and healthcare sectors in ASEAN. The Indonesian government launched a comprehensive national health insurance scheme in 2014 to ensure that all Indonesians have access to healthcare. Almost all ...
View more details
India's pharmaceutical and healthcare sector is globally recognised. India's reputation as the "pharmacy of the world" was established through its extensive production of generic medications and vaccines. For example, the Serum Institute of India, a ...
View more details